- INCREASE (inhaled treprostinil)
-
Product
INCREASE
(inhaled treprostinil)Therapeutic Platform
Tyvaso®Indication
Pulmonary Hypertension (PH) WHO Group 3Status
Phase IIIINCREASE - Phase III clinical trial with Tyvaso® (treprostinil) for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD).
LEARN MORE Close - PERFECT (inhaled treprostinil)
-
Product
PERFECT
(inhaled treprostinil)Therapeutic Platform
Tyvaso®Indication
Pulmonary Hypertension (PH) WHO Group 3Status
Phase IIIPhase III clinical trial with Tyvaso® (treprostinil) for the treatment of pulmonary hypertension due to chronic obstructive pulmonary disease (PH-COPD).
LEARN MORE Close
Menu
